Lucas A Horn

4PUBLICATIONS
30CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 24, 2026
Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

|Dec 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales

|Sep 07, 2023
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis.

Madeline Dahut, Kristen Fousek, Lucas A Horn

|Jun 28, 2022
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.

Christine M Minnar, Paul L Chariou, Lucas A Horn

Pageof 1

Frequent Collaborators

3 joint publications

Claudia Palena

3 joint publications

Jeffrey Schlom

2 joint publications

James L Gulley

1 joint publications

Christine M Minnar